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Linear mixedmodels (LMMs) are widely used in genome-wide association studies (GWASs) to account for population structure and relat-
edness, for both continuous and binary traits. Motivated by the failure of LMMs to control type I errors in a GWAS of asthma, a binary
trait, we show that LMMs are generally inappropriate for analyzing binary traits when population stratification leads to violation of the
LMM’s constant-residual variance assumption. To overcome this problem, we develop a computationally efficient logistic mixed model
approach for genome-wide analysis of binary traits, the generalized linear mixed model association test (GMMAT). This approach fits a
logistic mixed model once per GWAS and performs score tests under the null hypothesis of no association between a binary trait and
individual genetic variants. We show in simulation studies and real data analysis that GMMAT effectively controls for population struc-
ture and relatedness when analyzing binary traits in a wide variety of study designs.Introduction
Population stratification is a major source of confounding
in genetic association studies.1 With the recent develop-
ment of computationally efficient algorithms, linear
mixed models (LMMs) have become popular in genome-
wide association studies (GWASs) for controlling popula-
tion stratification, as well as familial or cryptic related-
ness.2–10 However, in human genetics, GWASs are often
conducted using binary traits; for example, case-control
studies sample disease subjects (case subjects) and dis-
ease-free subjects (control subjects) and collect their geno-
type and exposure data retrospectively. Cohort studies
follow a group of healthy subjects prospectively and collect
their subsequent status evaluations with respect to the
binary disease outcome. Despite the popularity of the use
of LMMs in binary trait GWASs, their reliance on a gener-
ally invalid assumption appears to have been overlooked.
Specifically, as typically used, LMMs assume that the trait
has constant residual variance, which is usually violated
by binary traits in the presence of covariates. As a conse-
quence, we will show that in the presence of population
stratification, fitting LMMs to binary traits can fail to con-
trol for type I error rates and yield incorrect p value esti-
mates. Typical use of LMMs also ignores the biased
sampling in case-control studies, which leads to biased ef-
fect estimates.
Our study of LMMs for binary traits was motivated by
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nally performed using LMMs with three random effects to
account for genetic relatedness as well as household and
block group membership from its multi-stage sampling
design. For asthma, ancestry is a known confounder of ge-
netic associations in Hispanic/Latino populations, and in
HCHS/SOL the proportion of asthma cases varies widely
by ancestry group (e.g., 25.6% in Puerto Ricans versus
4.1% in South Americans, see Table 1).11 Despite regression
adjustment for ancestry by including principal compo-
nents (PCs)12,13 and indicators for ancestry group as cova-
riates, the LMM results for this trait appear invalid
(Figure 1), showing clear conservatism/anti-conservatism
for variants with the minor allele that is respectively less
common/more common in Puerto Rican heritage versus
all other ancestry groups.
Based on published case-control GWASs,14–17 this con-
cerning behavior does not appear to be well known. Users
of LMMs for binary traits have appealed to Pirinen et al.,9
who showed that linear models are a sufficiently close
approximation to logistic models for p value calculations
when the effect size of a genetic variant is small and in
the absence of population stratification. We will show
that in the presence of population stratification, fitting
LMMs to binary traits in both cohort and case-control
studies can yield incorrect type I error rates in GWASs
due to heteroscedasticity, that is, residual variances in a
model that are not constant with respect to different values
of covariates.18 Like linear regression, LMMs assumen, MA 02115, USA; 2Computational and Systems Biology, Genome Institute
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Table 1. Numbers of Asthma Case Subjects and Control Subjects in
Six Hispanic/Latino Background Groups in HCHS/SOL after Quality
Control of Samples
Group
Case
Subjects
Control
Subjects
Sample
Size
Proportion
of Case
Subjects
Trait
Variance
Central
American
55 1,173 1,228 4.5% 0.043
Cuban 182 1,722 1,904 9.6% 0.086
Dominican 99 933 1,032 9.6% 0.087
Mexican 172 4,189 4,361 3.9% 0.038
Puerto
Rican
478 1,390 1,868 25.6% 0.190
South
American
34 795 829 4.1% 0.039
Trait variance is calculated as the product of proportions of case and control
subjects.homoscedasticity, that is, residual variances are constant
regardless of covariate values (Figure 2).19
Recently, liability threshold linear mixed models have
been proposed for case-control studies.20,21 Fitting these
models require knowing disease prevalence and accurate
heritability and liability estimates in the underlying study
population, whichmight not be available or might be diffi-
cult to specify in practice, especially when disease preva-
lence differs between subpopulation groups. For example,
in the HCHS/SOL, the asthma prevalence rates were
different in different ancestry background groups;11 in
case-control studies in the presence of population stratifi-
cation, it is difficult to specify the disease prevalence that
can be used for analysis when underlying subpopulation
groups are unknown and the disease prevalence rates
vary between underlying subpopulations. We will show
that these methods can fail to control for type I error
rates in the presence of moderate or strong population
stratification.
To address these issues, we propose using logistic mixed
models22 to account for both population stratification and
relatedness in genetic association studies of binary traits,
while naturally allowing for the non-constant variance of
these traits. Because logistic mixed models are computa-
tionally more expensive than LMMs and regular logistic
models, they have not been used in large-scale GWASs.
Although SAS PROC GLIMMIX allows for fitting logistic
mixed models with a genetic relationship matrix, it is
not feasible for large-scale GWASs because of its computa-
tional burden associated with fitting a large number of lo-
gistic mixed models, one per variant, across the genome.
We develop the generalized linear mixed model associa-
tion test (GMMAT), which requires fitting a logistic mixed
model under the null hypothesis only once per GWAS, and
is hence computationally feasible for large-scale GWASs.
Specifically, GMMAT first fits the null logistic mixed
model that includes as fixed effects only covariates,
including ancestry PCs, but no individual genetic variants,654 The American Journal of Human Genetics 98, 653–666, April 7, 2and uses random effects to account for residual population
stratification not captured by fixed effects PCs as well as
relatedness. When fitting this null model, GMMAT uses
penalized quasi-likelihood (PQL)22 and the computation-
ally efficient average information restrictedmaximum like-
lihood (AI-REML) algorithm.6,23 This fitted null model is
the same for all genetic variants in a GWAS. GMMAT
then applies a score test24 for each individual genetic
variant to test for its association with a binary trait. The
computational cost of the score test for each genetic
variant is negligible compared to the cost of fitting the
null logistic mixed model, so the procedure is computa-
tionally fast, even for large-scale GWASs.
As a full-modeling approach, GMMAT accounts for the
binary nature of the trait, in particular its non-constant
variance in the presence of covariates, and so correctly
controls type I error rates in the presence of population
stratification and relatedness. GMMAT can also allow for
complex sampling designs such as hierarchical designs
and allow for unobserved shared environmental effects
among sampled individuals by incorporating multiple
random effects.Material and Methods
Logistic Mixed Models and Score Tests
For a single-variant test, we consider the following logistic mixed
model:
logitðpiÞ ¼ XiaþGibþ bi;
where pi ¼ Pðyi ¼ 1
Xi;Gi; biÞ is the probability of a binary pheno-
type (e.g., disease status) for subject i, conditional on their covari-
ates, genotype, and random effects bi, Xi is a 1 3 p row vector of
covariates for subject i, a is a p3 1 column vector of fixed covariate
effects including an intercept, Gi is the genotype of a genetic
variant for subject i, and b is the genotype effect. We assume
that b  Nð0;PKk¼1tkVkÞ is an n 3 1 column vector of random ef-
fects, where tk are the variance component parameters and Vk are
known n 3 n relatedness matrices. When the number of variance
components K ¼ 1, V1 is usually the genetic relationship matrix
estimated from a large number of genetic variants. We allow for
multiple random effects to account for complex sampling designs,
e.g., hierarchical designs, and environmental covariance structure.
The binary phenotypes yi are assumed to be independent condi-
tional on the random effects b.
To perform the score test for the null hypothesis H0: b ¼ 0, we
need to fit the null logistic mixed model, which is the same for
all genetic variants, as
logitðpi0Þ ¼ Xiaþ bi; (Equation 1)
where pi0 ¼ Pðyi ¼ 1
Xi; biÞ. We fit Equation 1 using the penalized
quasi-likelihood (PQL) method.22 Specifically, let W ¼ diagfvi0g,
where vi0 ¼ pi0ð1 pi0Þ,X ¼

XT1 X
T
2 / X
T
n
T
be an n3 p co-
variate matrix including an intercept, and ~Y be the ‘‘working vec-
tor’’ with components ~Yi ¼ Xiaþ bi þ v1i0 ðyi  pi0Þ. Under the
null hypothesis H0: b ¼ 0, we iteratively fit the working linear
mixed model ~Y ¼ Xaþ bþ ε where ε  Nð0;W1Þ. We use the
computationally efficient AI-REML algorithm6,23 to estimate btk.
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Figure 1. Quantile-Quantile Plot of Association Test p Values from the Asthma GWAS Analysis in HCHS/SOL
(A) All SNPs.
(B) Category 1: SNPs with the ratio of expected variances in Puerto Ricans over non-Puerto Ricans less than 0.8.
(C) Category 2: SNPs with the ratio of expected variances in Puerto Ricans over non-Puerto Ricans between 0.8 and 1.25.
(D) Category 3: SNPs with the ratio of expected variances in Puerto Ricans over non-Puerto Ricans greater than 1.25.
Abbreviations are as follows: LMM, a joint analysis using LMMon the combined samples; LMMmeta, an inverse-variance weighted fixed
effects meta-analysis approach to combine LMM results from analyzing Puerto Ricans and non-Puerto Ricans separately.After obtaining the variance component estimates, the estimates
of the fixed effects ba and random effects bb can be updated, fol-
lowed by the working vector ~Y. The process continues until
convergence.
At each iteration, we perform a matrix inversion based on Cho-
lesky decomposition with complexity of O(n3) and matrix multi-
plications with complexity of O(pn2 þ K2n2 þ p2n), where n is
the sample size, p is the number of covariates, and K is the number
of variance components. Thus, the total complexity of fitting a lo-
gistic mixed model with K known relatedness matrices is O(in3 þ
ipn2 þ iK2n2 þ ip2n), where i is the number of iterations required
to reach convergence.
The score for H0: b ¼ 0 is T ¼ GT ðy bp0Þ, where G ¼
ðG1 G2 / Gn ÞT is the n 3 1 column vector of genotypes,
y ¼ ð y1 y2 / yn ÞT is the n 3 1 column vector of outcomes,
and bp0 is a vector of fitted values under H0, which is the
same for all SNPs. The estimated variance of the score isThe AmVarðT jH0Þ ¼ GT bPG under the null hypothesis, wherebP ¼ bS1  bS1XðXT bS1XÞ1XT bS1, and bS ¼ cW1 þPKk¼1btkVk.
The test for each genetic variant involves a vector-matrix-vector
multiplication and an inner product calculation for two vectors,
and thus the score test step has complexity of O(qn2 þ qn), where
q is the total number of genetic variants tested. Also, the score test
step can be easily parallelized if necessary. We use the Cþþ library
Armadillo to perform matrix and vector calculations. More details
about fitting the logistic mixed model and performing the score
test are given in Appendix A.HCHS/SOL Genotyping and Statistical Analysis
HCHS/SOL subjects who consented to genetic studies had DNA
extracted from blood. These DNA samples were genotyped on
the SOL HCHS Custom 15041502 B3 array (custom content de-
signed and developed by Papanicolaou, Rotter, and Taylor) aterican Journal of Human Genetics 98, 653–666, April 7, 2016 655
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Figure 2. True Mean-Variance Relationship for a Binary Trait
and the ConstantMean-Variance Relationship Assumed by Linear
Models, Illustrated by the Example from the Asthma Data in
HCHS/SOL
For a binary trait with the mean p, its variance is p(1  p), which
varies with the mean. This heteroscedasticity is properly ac-
counted for by logistic regression. Linear models inappropriately
assume that the variance of the binary trait does not change
with the mean and is a constant (homoscedasticity). For example,
the variance of the binary trait (asthma status) in Puerto Ricans is
considerably larger than the variances in the other five popula-
tions, because Puerto Ricans have a much higher asthma disease
proportion than the other populations. This heteroscedasticity
caused by population stratification results in the p values calcu-
lated from LMMs being likely to be incorrect, but is properly taken
into account by logistic mixed models using GMMAT.Illumina Microarray Services. This array comprised the Illumina
Omni 2.5M array (HumanOmni2.5-8v1-1) and additional custom
content selected for HCHS/SOL, including ancestry-informative
markers, variants characteristic of Amerindians, and known
GWAS hits.25 Illumina Microarray Services, LA Biomed, and the
SOL Genetic Analysis Center (GAC) performed quality control to
generate recommended SNP- and sample-level quality filters. Sam-
ples were checked for annotated versus genetic sex, gross chromo-
somal anomalies, relatedness and population structure, missing
call rates, batch effects, duplicate sample discordance, andMende-
lian errors. At the SNP level, checks were performed for Hardy-
Weinberg equilibrium, minor allele frequency (MAF), duplicate
probe discordance, and missing call rate.
Study participants were recruited via a multi-stage survey sam-
pling procedure, for which individuals were sampled within
households that were sampled within block groups.26 The study
includes genetic data from 12,803 individuals of Hispanic/Latino
origin, belonging to six different Hispanic/Latino background
groups.25 The HCHS/SOL study was approved by institutional re-
view boards at participating institutions, and written informed
consent was obtained from all participants. Standard quality con-
trol, similar to that described by Laurie et al.,27 was performed to
filter SNPs and samples of poor quality. Additionally, samples
missing information on asthma diagnosis and 56 samples identi-
fied as ancestry outliers from principal-component analysis were
removed, leaving a sample size of 11,222 for analysis. We also
filtered SNPs with a MAF less than 5% in this overall sample, re-656 The American Journal of Human Genetics 98, 653–666, April 7, 2sulting in a set of 1,299,221 autosomal SNPs to be analyzed. The
proportions of asthma cases in analyzed participants within
each of the genetic background groups of Central American, Cu-
ban, Dominican, Mexican, Puerto Rican, and South American
descent are 4.5%, 9.6%, 9.6%, 3.9%, 25.6%, and 4.1%, respectively
(Table 1). The Puerto Rican group is a clear outlier from the rest, so
we compared it to the collection of all other background groups,
which has a combined proportion of 5.8%. To account for poten-
tial shared environment effects resulting from the sampling
design, relatedness matrices representing household and block
group membership were included in addition to the standardized
genetic relationship matrix, totaling three random effects for the
linear and logistic mixed models. The top five PCs, as well as His-
panic/Latino background group indicators, were used to adjust for
ancestry in both models. Additional fixed effects covariates
included field center, sex, age, cigarette use, cigarette pack years,
and sampling weight (i.e., weights to account for disproportionate
selection of the sample according to the sample survey design26).
Treatment of sampling weight as a fixed effect in this way can
effectively adjust for the marginal effect of design variables.28Simulation Studies
We perform coalescent simulations29 to generate genotypes for a
total of 8,000 founders with 1,000,000 independent SNPs from a
203 20 grid (Figure S1) tomimic spatially continuous populations
(20 individuals per cell) withmigration rate between adjacent cells
M ¼ 10 to represent population structure within Europe.30,31 To
simulate genotypes of an offspring cohort, we first sampled
(without replacement) 10 pairs of parents for each cell of the
203 20 grid from the original cohort and then simulated two chil-
dren for each family using the gene dropping algorithm,32 thus
obtaining 8,000 individuals in the offspring cohort. We combined
the two cohorts to get 16,000 individuals with both population
structure and relatedness. For individual j in family i, the probabil-
ity of being a case pij was calculated from
logit

pij
 ¼ a0 þ a1Zi þ aij;
where Zi ¼ 1 if family iwas from a 103 10 grid in the top left, and
Zi ¼ 0 otherwise. The parameters a0 and a1 were chosen such that
the disease prevalence was 0.28 in the high-risk population group
in the top left given no random effects and 0.05 in the low-risk
population group given no random effects. The random effects
were simulated as
ai ¼
0BB@
ai1
ai2
ai3
ai4
1CCA  N
0BB@
0BB@
0
0
0
0
1CCA; s2
0BB@
1 0 0:5 0:5
0 1 0:5 0:5
0:5 0:5 1 0:5
0:5 0:5 0:5 1
1CCA
1CCA;
where the variance component parameter s2 was set to 2. We
randomly sampled 10,000 individuals from the combined original
and offspring cohorts to form a simulated cohort study, and their
standardized genetic relationship matrix was calculated using
625,583 genetic variants withMAF greater than 5% in the founder
population. We removed family indicators and compared linear
and logistic mixed models using the genetic relationship matrix.
We included the top ten ancestry PCs as covariates in bothmodels.
We analyzed common genetic variants with MAF greater than 5%.
In the simulated case-control study for rare disease, we chose a0
and a1 such that the disease prevalence was 0.045 in the high-
risk population group in the top left given no random effects
and 0.005 in the low-risk population group given no random016
effects. We randomly sampled 1,667 case subjects and 8,333 con-
trol subjects from the combined original and offspring cohorts to
form a case-control study with a total sample size of 10,000 and a
case-control ratio of 1:5. We performed the same analysis as
described above.Results
Analysis of HCHS/SOL Asthma GWAS Data
We compared the results from LMMs and logistic mixed
models using GMMAT for an analysis of physician-diag-
nosed asthma in the population-based HCHS/SOL cohort
study.
Figure 1A shows the behavior of the overall quantile-
quantile (QQ) plots from each method in the asthma anal-
ysis. The inflated results from the LMM are caused by
violation of its constant residual variance (homoscedastic-
ity) assumption. For binary traits, population stratification
affects both population-specific means (disease preva-
lences in cohort studies) and variances of the trait; popula-
tion groups with disease prevalence closer to 0.5 have
larger variances (Table 1 and Figure 2). The mean-variance
relationship assumed in linear models and LMMs is mis-
specified for binary traits. Although confounding by popu-
lation structure can be accounted for by adjusting for
population groups or ancestry PCs, unequal binary trait
variances across different populations are not appropri-
ately modeled in linear models and LMMs. The variance
of the standard LMM-based test statistic for no genetic as-
sociation is underestimated when population groups with
larger binary trait variances (i.e., higher disease risk) also
have higher MAFs, thus larger genotypic variances. This
leads to inflation in the test statistic, and vice versa.
To demonstrate this, we partitioned all common SNPs
across the genome into three categories based on their
genotypic variances in Puerto Ricans and non-Puerto
Ricans: (1) the SNPs with the ratio of expected variances,
that is Var(SNP) ¼ 2MAFð1MAFÞ, in Puerto Ricans
(high-risk group) over non-Puerto Ricans (low-risk group)
less than 0.8; (2) the SNPs with the ratio of Var(SNP) in
Puerto Ricans over non-Puerto Ricans between 0.8 and
1.25; and (3) the SNPs with the ratio of Var(SNP) in Puerto
Ricans over non-Puerto Ricans greater than 1.25. In this
classification, the category 1 SNPs (n ¼ 144,815 [11%])
have appreciably lower MAFs in Puerto Ricans (high risk)
than non-Puerto Ricans (low risk). The category 2 SNPs
have similar MAFs in both groups (n ¼ 982,805 [76%]).
The category 3 SNPs (n ¼ 171,601 [13%]) have appreciably
higher MAFs in Puerto Ricans (high risk) than non-Puerto
Ricans (low risk). Both LMMs and GMMAT perform well
for category 2 SNPs (Figure 1C). The problem with LMMs
is more apparent for category 1 and 3 SNPs: Figure 1B
shows conservative p values for category 1 SNPs, and
Figure 1D shows anti-conservative p values for category 3
SNPs, as expected. This indicates the p values calculated
from LMMs are likely to be incorrect for at least 24% of
SNPs in HCHS/SOL asthma GWASs. Meta-analysis byThe Amanalyzing Puerto Ricans and non-Puerto Ricans separately
after removing related individuals across the two groups
improves the LMM performance, but the results are still
not well calibrated for category 1 and 3 SNPs (Figures 1B
and 1D), probably due to the heteroscedasticity issue
caused by within-group population stratification. In
contrast, GMMAT performs well for all categories of SNPs
considered.
Simulation Studies
We also conducted extensive simulation studies under the
null hypothesis to illustrate this issue in various GWAS
case-control and cohort study designs, to exclude the pos-
sibility that LMM-inflated results in HCHS/SOL were
caused by polygenic effects. We restricted analyses to com-
mon SNPs with aMAF greater than 5%. First, in a simulated
cohort study of 10,000 individuals with cryptic related-
ness, we simulated two population groups with disease
prevalences of 28% (population 1) and 5% (population 2),
respectively, from a map of spatially continuous popula-
tions. The disease prevalences were chosen to mimic the
asthma disease proportions of Puerto Ricans and non-
Puerto Ricans in HCHS/SOL (Table 1). In both LMM and
GMMAT, we adjusted for the top ten ancestry PCs as fixed
effects covariates. Figure 3A includes results from 3,200
null simulated datasets with 625,583 SNPs and 10,000
related subjects per dataset. LMM has a type I error rate
of 1.26 3 107 at the nominal 5 3 108 level, compared
to 5.0 3 108 for GMMAT. Note that because more than
2 billion p values are included, type I error rate estimates
at this level are accurate with standard error 5 3 109.
Following the HCHS/SOL example, we partitioned all
the common SNPs into three categories: (1) the SNPs
with the ratio of expected variances in population 1
(high risk) over population 2 (low risk) less than 0.8; (2)
the SNPs with the ratio of expected variances in popula-
tion 1 over population 2 between 0.8 and 1.25; and (3)
the SNPs with the ratio of expected variances in popula-
tion 1 over population 2 greater than 1.25. Category 1
includes the SNPs that have appreciably lower MAFs in
population 1 than population 2 (24%). Category 2 in-
cludes the SNPs that have comparable MAFs in the two
populations (58%). Category 3 includes the SNPs that
have appreciably higher MAFs in population 1 than popu-
lation 2 (18%). For category 2 SNPs, both LMM and
GMMAT properly control for type I error rates (Figure 3C).
However, despite adjusting for ancestry PCs, LMMs have
deflated type I error rates for category 1 SNPs (Figure 3B)
and inflated type I error rates for category 3 SNPs (Fig-
ure 3D). LMMs often fail to control type I error rates in
the presence of moderate or strong population stratifica-
tion when differences in prevalence by population groups
cause large differences in binary trait variances between
populations, as demonstrated by our simulation studies
that were motivated by the HCHS/SOL study. However,
this issue is not always evident in the overall QQ plot using
all the SNPs in a GWAS, because the number of SNPs in aerican Journal of Human Genetics 98, 653–666, April 7, 2016 657
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Figure 3. A Simulated Cohort Study with 10,000 Related Individuals
Quantile-quantile plots of association test p values from 3,200 simulation replicates under the null hypothesis of no genetic association,
each with 625,583 common SNPs, were combined to get more than 2 billion null p values.
(A) All SNPs.
(B) Category 1: SNPs with the ratio of expected variances in population 1 (high risk) over population 2 (low risk) less than 0.8.
(C) Category 2: SNPs with the ratio of expected variances in population 1 (high risk) over population 2 (low risk) between 0.8 and 1.25.
(D) Category 3: SNPs with the ratio of expected variances in population 1 (high risk) over population 2 (low risk) greater than 1.25.typical GWAS is usually in the range of 105 and 106, confi-
dence intervals are relatively wide, and inflation and defla-
tion are likely to mask each other in the overall QQ plot.
To illustrate this, Figure S2 shows results from only one
simulated dataset with 625,583 common SNPs and
10,000 subjects in the same setting as Figure 3. There is a
slight indication of inflation for p values from LMMs in
Figure S2A, but the results are conservative for category 1
SNPs (n ¼ 151,206 [24%]) (Figure S2B) and anti-conserva-
tive for category 3 SNPs (Figure S2D) (n ¼ 111,455
[18%]). These results show that the p values from LMMs
might be incorrect for at least 42% of SNPs in this analysis,
even though inflation and deflation might not be obvious
in the overall QQ plot.
We next simulated a case-control study with a total sam-
ple size of 10,000 and a case-control ratio of 1:5 from the658 The American Journal of Human Genetics 98, 653–666, April 7, 2same two populations as in our simulated cohort study
in the presence of cryptic relatedness. Compared to cohort
studies, case-control studies oversample cases. The disease
prevalence was 4.5% and 0.5% in population 1 (high risk)
and population 2 (low risk), respectively. Figure S3A shows
that GMMAT works well according to the QQ plot of
p values. The genomic control inflation factors show
that both LMM and GMMAT have appropriate median
p values. However, type I error rates at the nominal level
of 5 3 108 are 1.75 3 107 for LMM and 4.6 3 108 for
GMMAT, respectively. Moreover, when we divided the
SNPs into three categories as we previously described, we
observed strong deflation for category 1 SNPs (Figure S3B)
and strong inflation for category 3 SNPs (Figure S3D) from
LMM analysis, as seen in the simulated cohort study. Addi-
tional simulation studies show that the same problem for016
LMMs also exists in cohort studies without cryptic related-
ness in the presence of population stratification (Figure S4).
Although confounding by discrete populations can be
appropriately accounted for by analyzing each population
separately via LMMs followed by meta-analysis (Figure S5),
this strategy does not perform well in the presence of con-
founding by continuous population structure (Figure S6).
Moreover, LMMs do not work well in case-control studies
of unrelated individuals with moderate to strong popula-
tion stratification (Figure S7). These suggest that despite
its wide use in both population-based and family-based
genetic association studies, LMMs are generally not appro-
priate for binary traits due to misspecified phenotype vari-
ance in the model, probably yielding incorrect p values
(see Appendix B for details).
We also performed additional simulations to compare
GMMAT with ROADTRIPS, which performs a retrospec-
tive test for association in case-control data,33 and the
recently developed liability estimator as a phenotype
(LEAP) approach. LEAP fits a liability mixed model that
accounts for case-control ascertainment.20 In the same
case-control setting as that described for Figure S7,
ROADTRIPS was not well calibrated due to failure to
fully account for population stratification. LEAP was
found to have well-behaved overall QQ plots but inflated
type I error rates for category 1 SNPs, regardless of
whether top ten ancestry PCs were adjusted as covariates
or not (Figure S8).
We next simulated case-control studies with the disease
prevalence of 1% by varying the case-control sampling
ratios in two population groups. We first considered
balanced cases and controls in the two populations. Spe-
cifically, when the case-control ratio is 1:1 in both groups,
there is no population stratification, and ROADTRIPS,
LEAP, LMMs, and GMMAT all properly control for type I
error rates (Figure S9). When the case-control ratios
are different but flipped in two populations (4:1 in popu-
lation 1 and 1:4 in population 2), there is population
stratification. However, because the variance of the
binary trait is the same in both population groups in
this situation, LMMs and GMMAT both perform well,
whereas ROADTRIPS has inflated type I error rates in
the tail and LEAP has an appropriate overall QQ plots
but inflated or deflated type I error rates for the SNPs
whose MAFs are different in the two population groups
(Figure S10).
We also considered a situation where the case-control
ratios are different in two populations (25:2 in population
1 and 25:48 in population 2) in a way that led to a
smaller variance of the binary trait in population 1
than in population 2. ROADTRIPS and LEAP adjusting
for the top ten PCs show inflation in the overall
QQ plot, and LEAP without covariates and LMMs have in-
flated type I error rates for category 1 SNPs and deflated
type I error rates for category 3 SNPs (Figure S11). In terms
of required computational resources, LEAP requires more
than 20 times the amount of memory compared toThe AmGMMAT for an analysis of a case-control study of sample
size 10,000.
We also performed simulation studies to evaluate the
performance of GMMAT in estimating odds ratios of ge-
netic variants. We found that GMMAT had minor bias in
estimating odds ratios when fitting logistic mixed models
under the null and alternative hypotheses, compared to
the true parameter values in large samples (n ¼ 10,000).
In addition, the performance in terms of absolute bias ap-
pears to be similar to that using MACAU,34 a recently
developedMarkov Chain Monte Carlo-based mixed model
approach for binomial count data, while the GMMATodds
ratio estimates are less variable (Figure S12).
In the absence of population stratification, LMMs and
GMMAT have comparable power, but they are both
less powerful than logistic regression (Table S1). In the
presence of population stratification, LMMs have less
power than GMMAT for causal genetic variants with a
lower MAF in the high-risk population than in the low-
risk population (Table S1), due to its conservative type I
error rate control for such variants, as shown in
Figure S4B.
Computational Speed and Memory Usage
We benchmarked our GMMAT package against SAS PROC
GLIMMIX regarding computational speed and memory
usage. To fit a null model with sample size 2,000, GMMAT
takes less than 1.5% of the time required by SAS PROC
GLIMMIX when fitting a logistic mixed model with one
variance component, and less than 0.6% of the time
with three variance components (Table S2), yielding the
same numerical results to at least the fourth decimal
place. On average, with one variance component of
random effects, as is commonly used to account for ge-
netic relatedness in GWASs, SAS PROC GLIMMIX requires
about 28 min to fit a null model on a single core of an In-
tel Xeon E5-2690 CPU (2.90 GHz), compared to about
22 s using GMMAT. With three variance components of
random effects that account for complex sampling de-
signs in addition to genetic relatedness, SAS PROC
GLIMMIX requires about 1.2 hr, whereas GMMAT needs
still about 22 s. It takes about 14 min for GMMAT to
perform score tests for 1,000,000 genetic variants on the
same core, without parallelization. In practice, score tests
for different variants can be easily run in parallel in a
computing cluster, and testing each genetic variant takes
only about 0.8 ms.
GMMAT requires less than 1 GB memory in analyzing
2,000 individuals. With sample size 10,000, it takes about
18 min to fit the null model with one variance component
and 34 min with three variance components using
GMMAT, and about 3.6 hr to perform score tests for
1,000,000 genetic variants on a single core (about 13 ms
for testing each genetic variant) (Table S2). SAS PROC
GLIMMIX reports insufficient memory when 100 GB
memory is specified to fit the null model for 10,000 indi-
viduals, whereas GMMATrequires less than 14 GBmemoryerican Journal of Human Genetics 98, 653–666, April 7, 2016 659
for one variance component and 21 GB for three variance
components.Discussion
We have proposed in this paper using logistic mixed
models to correct for population stratification and related-
ness in analyzing binary traits in GWASs. The proposed
GMMAT performs computationally efficient score tests
for genetic associations in cohort and case-control GWASs
with binary traits. We demonstrate that GMMAT is effec-
tive in controlling type I error rates. In contrast, even
when ancestry terms are included as covariates, applying
LMMs to binary traits can lead to incorrect type I error rates
in the presence of population stratification, particularly
when population groups have heterogeneous disease risks
or case-control ratios that result in different binary trait
variances. In such scenarios, LMMs are approximately
valid only when the MAF of the genetic variant being
tested for association is roughly the same in all population
groups, i.e., in the presence of no or weak confounding by
population structure. The homoscedasticity assumption
underlying standard LMMs is essential but has largely
been ignored in previous genetic association studies that
used LMMs for binary traits. Despite the widespread belief
that LMMs can be used to account for population stratifica-
tion for both continuous and binary traits, our results
show that LMMs can lead to incorrect type I error rates
and p values in the presence of population stratification
and relatedness. Recently, Conomos et al.25 showed that
violation of the homoscedasticity assumption could also
happen for continuous traits, and a model allowing for
group-specific residual variances outperformed standard
LMMs in such scenarios. For binary traits in discrete popu-
lation groups, when there is no or weak confounding by
population structure within each group, we have shown
that meta-analysis is a valid and effective approach for
combining results from analyzing each group separately
using LMMs (Figure S5). Moreover, we can use logistic
regression to analyze homogeneous unrelated samples,
which is more powerful than LMMs and GMMAT (Table
S1). In reality, however, population groups with no or
weak within-group confounding might not always be
clearly defined in large-scale genetic association studies,
especially for admixed populations. When within-group
population stratification remains, we have also shown
that a meta-analysis approach using LMMs is still mis-cali-
brated similarly to the standard LMM approach (Figure S6).
Furthermore, it is often difficult to check the validity of
LMMs by comparing group-specific binary trait variances
and MAFs. In contrast, such checking is not required by
GMMAT when fitting logistic mixed models.
In practice, QQ plots have been widely used for model
diagnostics in GWASs. Our results show that a well-
behaved QQ plot is not sufficient to identify invalid results
due to model misspecification. Specifically, an overall QQ660 The American Journal of Human Genetics 98, 653–666, April 7, 2plot can appear to show LMMs properly controlling type
I error rates for binary traits (Figure S2A), but this might
just reflect balancing out of conservative p values and
anti-conservative p values of different subsets of SNPs (cat-
egories 1 and 3) (Figures S2B and S2D). It is important to
note that these errors (incorrect p values) do not ‘‘cancel
out;’’ spuriously significant results, i.e., type I errors, are
not ‘‘corrected’’ by omission of true signals, i.e., type II er-
rors. More generally, looking just at the overall QQ plot of
all SNPs can lead to unwarranted beliefs that analyses (e.g.,
use of standard LMMs for binary traits) are appropriate,
when they can have serious deficiencies for large propor-
tions of the results.
In case-control studies, which oversample cases, LMMs
are subject to incorrect type I error rates due to unequal
variances of binary traits caused by population stratifica-
tion introduced by unequal case-control ratios from
different sampling schemes across population groups,
even if the disease prevalence is the same in all the subpop-
ulations and the overall case-control ratio is 1:1 (Fig-
ure S11). Because ROADTRIPS currently does not allow
for covariate adjustment, it does not work well in the pres-
ence of moderate to strong population stratification.35 The
recently developed liability mixed models20,21 require ac-
curate estimation of the disease prevalence as well as heri-
tability and liability in the underlying overall population,
which can be difficult to obtain in practice in the presence
of population stratification and unknown subpopulation
groups. These models are generally applicable in the pres-
ence of no or weak population stratification, e.g., when
the case-control ratios are the same across populations,
but can fail to control for type I error rates in the presence
of moderate or strong population stratification, e.g., when
the case-control ratios differ between populations. They
also currently cannot handle multiple random effects in
addition to those accounting for genetic relatedness,
such as household and block groups in HCHS/SOL. The li-
ability threshold mixed linear model (LTMLM) approach is
applicable only to population-based case-control study de-
signs with no confounders and low levels of relatedness,
because it cannot adjust for covariates or handle family
data.21 The LEAP method can accommodate covariates
and be applicable to family data, but inclusion of covari-
ates presents both technical and statistical challenges.20
GMMAT provides a flexible method that does not require
knowing disease prevalence or heritability and liability es-
timates, and provides valid p values while properly con-
trolling for type I error rates.
Recently, Song et al.36 proposed a genotype-conditional
association test that accounts for population structure in
association tests. However, as pointed out by the authors,
their approach does not account for family or cryptic relat-
edness. In contrast, our logistic mixed model approach is
more flexible and can account for both population struc-
ture and relatedness in population-based and family-based
cohort and case-control studies, as well as complex sam-
pling designs (as illustrated in our HCHS/SOL asthma016
example). Therefore, our approach can be applied to a
much wider range of genetic association studies with fam-
ily data, cryptic relatedness, unobserved shared environ-
mental effects, and non-random sampling study designs,
in addition to population stratification, without the need
to model them in different ways.
We provide an open-source R package GMMAT for
fitting logistic mixed models and performing score-based
tests in GWASs. The package can also be applied to other
types of continuous and discrete traits in the general
framework of generalized linear models37 that allow for
different link functions and different mean-variance rela-
tionships. Furthermore, the score statistics obtained from
different studies of the same disease can be easily com-
bined in meta-analysis.38
The recently proposed MACAU algorithm34 imple-
mented Wald tests in mixed models for binomial count
data using a Markov Chain Monte Carlo-based approach.
However, performing Wald and likelihood ratio tests for a
large number of individual variants via logistic mixed
models is currently computationally impractical for mod-
erate- to large-sample GWASs and would require future
research on developing efficient algorithms. Unlike linear
mixed models, logistic mixed models can be directly used
to estimate odds ratios by fitting the models under the
alternative hypothesis. It is computationally feasible to es-
timate odds ratios by fitting alternative logistic mixed
models for a subset of candidate genetic variants of inter-
est. If computational issues can be resolved in the future,
logistic mixed models can also be useful for risk prediction
in GWASs.Appendix A: Derivation of GMMAT
The Generalized Linear Mixed Model
The derivations below are based on generalized linear
mixed models (GLMMs), and logistic mixed models are a
special case of GLMMs when the link function is logit
and the dispersion parameter is fixed at 1. In the context
of single-variant test, we consider the following GLMM
hi ¼ gðmiÞ ¼ Xiaþ Gibþ bi;
whereXi is a 13 p row vector of covariates for subject i, a is
a p 3 1 column vector of fixed covariate effects including
the intercept, Gi is the genotype of the genetic variant of
interest for subject i, and b is the fixed genotype effect.
We assume that b  Nð0;PKk¼1tkVkÞ is an n 3 1 column
vector of random effects, tk are the variance component
parameters, t is a K 3 1 column vector of tk, and Vk are
known n 3 n matrices. We also assume that given the
random effects b, the outcome yi is conditionally indepen-
dent with mean Eðyi
bÞ ¼ mi and variance Varðyi bÞ ¼
fa1i vðmiÞ, where f is the dispersion parameter (for binary
and Poisson data f ¼ 1), ai are known weights, and vð,Þ
is the variance function. The linear predictor hi is a monot-
onous function of the conditional mean mi via the linkThe Amfunction hi ¼ gðmiÞ. For binary traits yi, mi ¼ pi ¼
Pðyi ¼ 1
Xi;Gi; biÞ is the probability of the binary outcome
(e.g., disease status) for subject i.
For subject i, the quasi-likelihood given random
effects b is
qliða; b;bÞ ¼
Z mi
yi
ai

yi  m

fvðmÞ dm:
The log integrated quasi-likelihood function of ða; b;f; tÞ is
qlða; b;f; tÞ ¼ log
Z
exp
(Xn
i¼1
qliða; b;bÞ
)
3 ð2pÞn2 j
XK
k¼1
tkVk j
1
2
3 exp
8<: 12bT
 XK
k¼1
tkVk
!1
b
9=;db:
(Equation A1)
Let
f ðbÞ ¼
Xn
i¼1
qliða; b;bÞ  1
2
bT
 XK
k¼1
tkVk
!1
b;
we can use Laplace method to approximate the n-dimen-
sional integral
Z
expff ðbÞgdbzð2pÞ
n
2 j  f 00

~b

j
1
2
exp
n
f

~b
o
;
thus Equation A1 becomes
qlða; b;f; tÞ ¼  1
2
log j
XK
k¼1
tkVk j  1
2
log j  f 00

~b

j
þ f

~b

;
(Equation A2)
where
~b ¼ argmax
b
f ðbÞ
is the solution of f 0ðbÞ ¼ 0.
The first partial derivative of qliða; b;bÞ with respect
to b is
vqli
vb
¼ vqli
vmi
vmi
vhi
vhi
vb
¼ ai

yi  mi

fvðmiÞ
1
g 0ðmiÞ
ZTi ;
where Zi is a 1 3 n vector of indicators such that bi ¼ Zib,
In ¼

ZT1 Z
T
2 / Z
T
n

, and the second derivative is
v2qli
vbvbT
¼  aiZ
T
i Zi
fvðmiÞ½g 0ðmiÞ2
 ai

yi  mi

v0ðmiÞZTi Zi
fv2ðmiÞ½g 0ðmiÞ2
 ai

yi  mi

g 00ðmiÞZTi Zi
fvðmiÞ½g 0ðmiÞ3
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For canonical link functions, vðmiÞg 0ðmiÞ ¼ 1, the last two
terms become 0. Let
D ¼ diagfg 0ðmiÞg;
W ¼ diag
(
ai
fvðmiÞ½g 0ðmiÞ2
)
;
then Equation A2 becomes
qlða; b;f; tÞ ¼ 1
2
log j
XK
k¼1
tkVk j  1
2
log j
Xn
i¼1
aiZ
T
i Zi
fvðmiÞ½g 0ðmiÞ2
þ
 XK
k¼1
tkVk
!1
j þ
Xn
i¼1
qli

a; b; ~b

 1
2
~b
T
 XK
k¼1
tkVk
!1
~b
¼ 1
2
log j
XK
k¼1
tkVkWþ I j þ
Xn
i¼1
qli

a; b; ~b

1
2
~b
T
 XK
k¼1
tkVk
!1
~b:
(Equation A3)
We assume that the weight matrix W changes slowly
with respect to the conditional means (following Breslow
and Clayton22), that is
vW
vmi
z0;
then we take the derivatives of Equation A3:
vqlða; b;f; tÞ
va
¼
Xn
i¼1
ai

yi  mi

fvðmiÞ
1
g 0ðmiÞ
XTi ¼ XTWDðy mÞ;
vqlða; b;f; tÞ
vb
¼
Xn
i¼1
ai

yi  mi

fvðmiÞ
1
g 0ðmiÞ
Gi ¼ GTWDðy mÞ;
(Equation A4)
vqlða; b;f; tÞ
vb
¼
Xn
i¼1
ai

yi  mi

fvðmiÞ
1
g 0ðmiÞ
ZTi 
 XK
k¼1
tkVk
!1
b
¼WDðy mÞ 
 XK
k¼1
tkVk
!1
b:
Under the null hypothesisH0 : b ¼ 0, if f and t are known,
we jointly choose baðf; tÞ and bbðf; tÞ to maximize Equa-
tion A3, then bbðf; tÞ ¼ ~bðbaðf; tÞ; b ¼ 0Þ because ~b maxi-
mizes f(b) for given ða; bÞ. Defining the working vector ~Y
with elements ~Yi ¼ hi þ g 0ðmiÞðyi  miÞ, the solution of
8<:
XTWDðy mÞ ¼ 0
WDðy mÞ ¼
 XK
k¼1
tkVk
!1
b
can be written as the solution to the system662 The American Journal of Human Genetics 98, 653–666, April 7, 224XTWX XTW
WX
 XK
k¼1
tkVk
!1
þW
35 a
b

¼

XTW~Y
W~Y

:
Let S ¼W1 þPKk¼1tkVk, P ¼ S1  S1XðXTS1XÞ1
XTS1, then
8><>:
ba ¼ XTS1X1XTS1 ~Y
bb ¼ 	XK
k¼1
tkVk
!
S1

~YXba
is the solution that maximizes Equation A3. We note that
~Y bh ¼ ~YXba  bb ¼ (I XK
k¼1
tkVk
!
S1
)
~YXba
¼W1S1~YXba ¼W1P~Y:
Estimation of Variance Component Parameters
Following Breslow and Clayton,22 we ignore the depen-
dence of W on t and use Pearson chi-square statistic to
approximate the deviance
2f
Xn
i¼1
qliða; b;bÞ ¼
Xn
i¼1
2
Z mi
yi
ai

yi  m

vðmÞ dm
z
Xn
i¼1
ai

yi  mi
2
vðmiÞ
:
Then Equation A3 at the maximum becomes
qlðbaðf; tÞ; b ¼ 0;f; tÞz 1
2
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XK
k¼1
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2
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
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 XK
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2
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2
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Similarly, the restricted maximum likelihood (REML)
version is016
qlRðbaðf; tÞ; b ¼ 0;f; tÞ ¼ cR  1
2
log jS j
 1
2
log jXTS1X j  1
2
~Y
T
P~Y:
Let V0 ¼ diagfa1i vðmiÞ½g 0ðmiÞ2g ¼ f1W1, then S ¼
fV0 þ
PK
k¼1tkVk, and the first derivatives of qlRðbaðf; tÞ;
b ¼ 0;f; tÞ with respect to f and t are
vqlRðbaðf; tÞ; b ¼ 0;f; tÞ
vf
¼ 1
2


~YPV0P~Y trðPV0Þ

;
vqlRðbaðf; tÞ; b ¼ 0;f; tÞ
vtk
¼ 1
2


~YPVkP~Y trðPVkÞ

:
We define the average information6,23 matrix AI with
the following entries
AIff ¼ 1
2
~YPV0PV0P~Y;
AIftk ¼
1
2
~YPV0PVkP~Y;
AItktl ¼
1
2
~YPVkPVlP~Y:
Let q be the variance component parameters to estimate,
when fs1, q ¼ ðf; tÞ, and AI is a (K þ 1)3(K þ 1) matrix.
For binary and Poisson data, f ¼ 1, q ¼ t, andAI is a K3 K
matrix containing only AItktl.
We use the following algorithm to fit the null GLMM:
1. Fit a generalized linear model with t ¼ 0 and get bað0Þ
and working vector ~Y
ð0Þ
;
2. Use qð0Þ ¼ Varð~Yð0ÞÞ=K (if f ¼ 1) or qð0Þ ¼ Varð~Yð0ÞÞ=
ðK þ 1Þ (if fs1) as the initial value of q;
3. For each k ¼ 0;1;.;K, update q using qð1Þk ¼
q
ð0Þ
k þ 2n1fqð0Þk g2ðvqlRðqð0ÞÞ=vqkÞ;
4. Use ~Y
ð1Þ ¼ ~Yð0Þ as ~Y and update qð2Þ ¼ qð1Þþ
fAIð1Þg1ðvqlRðqð1ÞÞ=vqÞ;
5. Calculate bað2Þ and bbð2Þ using ~Yð1Þ and qð2Þ;
6. Update ~Y
ð2Þ
using bað2Þ and bbð2Þ;
7. Repeat steps 4–6, until 2 maxfbaðiÞ  baði1Þ  =
ðbaðiÞþ baði1Þ  Þ; bqðiÞ  bqði1Þ  =ðbqðiÞ  þ bqði1Þ  Þg%
tolerance.The Score Test
Once ðba; bf; btÞ is estimated under the null hypothesis
H0 : b ¼ 0, the score test can be constructed by evaluating
Equation A4 at ðba; b ¼ 0; bf; btÞ, that is
T ¼ vql
ba; b ¼ 0; bf; bt
vb
¼ GTcWbDðy bmÞ ¼ GTcW~Y bh
¼ GT bP ~Y :
Its variance under the null hypothesis isThe AmVarðT j H0Þ ¼ E
(
vql
ba; b ¼ 0; bf; bt
vb
vql
ba; b ¼ 0; bf; bt
vbT
)
¼ E

GT bP ~Y ~YT bPG ¼ GT bPG;
the last equality holds because bP bS bP ¼ bP.
Appendix B. Additional Simulation Studies
Unrelated Individuals with Population Stratification
We performed additional simulation studies to compare
LMM and GMMAT in unrelated individuals in the pres-
ence of population stratification. We used the coalescent
model29 to simulate genotypes for a total of 16,000 unre-
lated individuals with 1,000,000 genetic variants from a
20 3 20 grid (Figure S1) of spatially continuous popula-
tions (40 individuals per cell) with migration rate between
adjacent cellsM¼ 10 tomimic population structure within
Europe.30,31 For individual i, the probability of being a case
pi was calculated from
logitðpiÞ ¼ a0 þ a1Zi;
where Zi ¼ 1 if individual i was from a 10 3 10 grid in the
top left (population 1) and Zi¼ 0 otherwise (population 2).
The parameters a0 and a1 were chosen such that the dis-
ease prevalence was 0.28 in population 1 (high risk) and
0.05 in population 2 (low risk). Note that the mean
model is not mis-specified when a linear link function is
used, thus our simulation setting is not in favor of logistic
models. We randomly sampled 10,000 individuals to form
a simulated cohort study for common disease (Figure S4)
and calculated their standardized genetic relationship
matrix using 625,504 genetic variants with MAF greater
than 5%. We adjusted for top ten PCs in both models
and combined results from 3,200 null simulation repli-
cates. We compared our method with the strategy in
which population 1 and population 2 were analyzed sepa-
rately using LMMs and the results were subsequently com-
bined in a meta-analysis (which we referred to as LMM
meta), using 100 null simulation replicates (Figure S5).
Moreover, we considered continuous population stratifica-
tion where Zi for each cell is the minimum of its row and
column coordinates in Figure S1, which ranges from 0 to
19, and a0 was chosen such that the disease prevalence
in populations with Zi ¼ 0 was 0.02 and a1 ¼ 0:2
(Figure S6).
We also simulated a case-control study for rare disease
(Figure S7). We chose a0 and a1 such that the disease prev-
alence was 0.045 in population 1 (high risk) and 0.005 in
population 2 (low risk). We randomly sampled 1,667 case
subjects and 8,333 control subjects to form a case-control
study with a total sample size of 10,000 and a case-control
ratio of 1:5. We performed the same analysis as described
above and combined results from 3,200 null simulation
replicates.erican Journal of Human Genetics 98, 653–666, April 7, 2016 663
Comparison with the Existing Methods
We also compared GMMAT with ROADTRIPS33 and the
recently developed liability (probit) mixed models.20,21
ROADTRIPS does not allow for covariates. Because
LTMLM21 does not allow covariate adjustment, we used
LEAP20 and set the disease prevalence to 0.015, which is
the pooled prevalence in both high- and low-risk popula-
tion groups. We compared ROADTRIPS and LEAP without
covariates as well as LEAP adjusting for top ten PCs as co-
variates with LMM and GMMAT. The simulation settings
were the same as in Figure S7, but p values from only
one simulation replicate were shown (Figure S8).
Moreover, we simulated three case-control settings with
the same prevalence but different case-control sampling
schemes in two population groups in Figure S1. The disease
prevalence was set to 0.01 in both groups. We compared
ROADTRIPS and LEAP with and without adjusting for
top ten PCs, with LMM and GMMAT.
In the first setting, we randomly sampled 1,250 case sub-
jects and 1,250 control subjects from population 1 and
3,750 case subjects and 3,750 control subjects from popu-
lation 2. This was a balanced case-control study with
balanced designs in both population groups. Because the
case-control ratio was the same, there was no population
stratification (Figure S9).
In the second setting, we randomly sampled 2,000 case
subjects and 500 control subjects from population 1 and
1,500 case subjects and 6,000 control subjects from popu-
lation 2. This was an unbalanced case-control study with
unbalanced designs but equal binary trait variances in
two population groups. Population stratification was
created by different case-control ratios in two population
groups (4:1 in population 1 and 1:4 in population 2),
instead of different disease prevalence (Figure S10).
In the third setting, we randomly sampled 2,500 case
subjects and 200 control subjects from population 1 and
2,500 case subjects and 4,800 control subjects from popu-
lation 2. This was a balanced case-control study with un-
balanced designs and unequal binary trait variances in
two population groups. Because the disease prevalence
was 0.01 in both groups, there were no high-risk or low-
risk groups, but population 1 was the low binary trait vari-
ance group with variance 0.0686 and population 2 was the
high binary trait variance group with variance 0.2252
(Figure S11).Simulations with Genetic Effects
We first conducted simulation studies to evaluate the per-
formance of GMMAT for estimating the odds ratios of ge-
netic variants in the presence of population stratification.
We used the same genotype data as in our null simulations
of unrelated individuals with population stratification. For
individual i, the probability of being a case pi was calcu-
lated from
logitðpiÞ ¼ a0 þ a1Zi þ bGi;664 The American Journal of Human Genetics 98, 653–666, April 7, 2where Zi ¼ 1 if individual i was from population 1, Zi ¼ 0
otherwise (population 2). Gi is the additively coded
genotype for the causal genetic variant. The parameters
a0 and a1 were chosen such that the disease prevalence
was 0.28 in population 1 and 0.05 in population 2 for
individuals with Gi ¼ 0. b was chosen such that the
odds ratio varied from 1.0, 1.1, 1.25, 1.5, to 2.0. The
total sample size was 10,000. We compared the odds
ratio estimates and the p values calculated by GMMAT
and MACAU (Figure S12). We then compared the power
of LMM and GMMAT for identifying causal variants
that had lower MAFs in population 1 than population 2
(Table S1).
We also simulated a case-control study with 1,667
case subjects and 8,333 control subjects with no
population stratification. We assumed the disease preva-
lence was 0.01 for individuals with Gi ¼ 0 and used
the same sampling scheme in both population 1 and
population 2. We compared the powers of logistic regres-
sion, LMM, and GMMAT for identifying causal variants
(Table S1).Supplemental Data
Supplemental Data include 12 figures and 2 tables and can be
found with this article online at http://dx.doi.org/10.1016/j.
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